1[1]Stetle-Steverson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion:from correlation and causeality to clinic. Sem in Cancer Bio. 1996,7:147-145
2[2]Liotta LA, Stetler-Stevensen WG. tumor Invasion and Metastasis:An Imbalance of Positive and Negative regulation. Cancer Res. 1991 (suppl);51:5054
3[3]Pavloff N, Starus PW, Kishnani NS. A New Inhibitor of Metalloproteinases from Chicken: ChIMP-3. J Biol Chem, 1992,267:17321-17326
4[4]Denhardt DT, Feng B, Edwards DR, et al. Tissue Inhibitor of Metalloproteinases(TIMP, aka EPA): Structure, control of Expression and Biological Functions. Pharamc Them, 1993,59:329
5[5]Greene J. Molecular cloaing and Characterization of Human Tissue Inhibitor of Metalloproteinases 4.J Biol Chem, 1996,271:30375-30380
6[6]Lee E, Vaughan DE, Parikh SH. regulation of Matrix Metalloproteinase and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells. Circ Res, 1996,78:44-49
7[7]Khokha R. Antisense RNA-Induce Reluction in Murine TIMP Level Confers Oncogenicity on Swiss 3T3 C ells. Science, 1989,243:949
8[8]Kaya-m.A single ets-related transcription, EIAF, confers invasive phenotype on human cancer cells. Oncogene, 1996 Jan 18,12:221-227
9[9]Khokha R. Zimmer MJ, Graham CH. Suppression of Invasion by Inducible Expression of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) IN B16-F10 Melanoma cells. J National Cancer Institute, 1992,84:1017
10[10]Declerk YA. Inhibition of Invasion and Metastasis in Cell Transfected with an Inhibitor of Metalloproteinases. Cancer Res, 1992,52:701
4Nawrockl B, Poiitte M, Marchard V, et al. Expression of matrix onclallproteinases and their inhibitors in human bronchopulmaonar, carcinomas: quantificative and morphological analyses.Int J Cancer, 1997,72:556-564.
5Khokha R,Micheal B,Tsao M,et al. Expression and prognostic signficance of metallproteinases and their tissue inhibitor in patients with small cell lung cancer. J Clin Oncol, 1999,17:1802-1808.
6Van Belzen N, Dinjens WN, Eussen BH, et al. Expressionof differentiation-related genes in colorectal cancer: possible implications for prognosis[ J]. Histol Hitopathol, 1998,13(4) :1233 -1242.
7Bandyopadhyay S, Pai SK, Hirota S, et al. Role of the putative tumor metastasis uppressor gene Drg-1 in brest cancer progression [ J ]. Oncogene, 2004, 23 ( 33 ) :5675 - 5681.
8Chang JT, Wang HM, Chang KW, et al. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHESI[J]. Int J Cancer, 2005, 114(6) :942 -949.
9Bandyopadhyay S, Pai SK, Gross SC, et al. The Drg-1 gene suppresses tumor metasis in prostate cancer[ J]. Cancer Res, 2003,63 (8) :1731 -1736.
10Lachat P, Shaw P, Gebhard S, et al. Expression of NDRG1, a differentiation-related gene, in human tissues [ J ]. Histochem Cell Biol, 2002,118 ( 5 ) :399 - 408.
